TTIPFOTCFiscal year ends February 28
Thiogenesis Therapeutics, Corp.
$0.37+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About Thiogenesis Therapeutics
Thiogenesis Therapeutics, Corp. is listed on OTC under the ticker TTIPF. It is incorporated in A6 and its fiscal year ends on February 28.
Company profile
Company
- Legal name
- Thiogenesis Therapeutics, Corp.
- Headquarters
- Toronto, A6
- Address
- 4 King Street West, Suite 401 M5H 1B6
- Phone
- (647) 846-7766
- Incorporated in
- A6
- Fiscal year ends
- February 28
Stock & identifiers
- Ticker
- TTIPF
- Exchange
- OTC
- IPO date
- Jan 24, 2025
- SEC CIK
- 1877778
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Thiogenesis Therapeutics's leadership is listed in its proxy statement (Form DEF 14A).
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 11, 2021 | Name change | Name changed from Rozdil Capital Corp to Thiogenesis Therapeutics, Corp. |